Seattle Genetics Announces Publication of Results from Two Tucatinib Phase 1b Clinical Trials in HER2-Positive Metastatic Breast Cancer
Wall Street Online Denmark,
(Nasdaq:SGEN) today announced that results of a phase 1b clinical trial of tucatinib in combination with standard of care…